Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma. - Wikidata - wikimedia - TriplyDB

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

http://www.wikidata.org/entity/Q46664514

about

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma.The role of high-dose chemotherapy supported by hematopoietic stem cell transplantation in patients with multiple myeloma: implications for nursing Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma.Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma.Thalidomide in multiple myeloma: past, present and future.Immunotherapy of multiple myeloma: the start of a long and tortuous journey.Multiple myeloma in the marrow: pathogenesis and treatments.Melphalan and its role in the management of patients with multiple myeloma.Melphalan: old and new uses of a still master drug for multiple myeloma.Novel anti-myeloma agents and angiogenesis.Review of thalidomide in the treatment of newly diagnosed multiple myeloma.Modern treatment options for elderly patients with multiple myeloma.Role of thalidomide in previously untreated patients with multiple myeloma.Front line treatment of elderly multiple myeloma in the era of novel agents.Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial.Palliative oncology: thalidomide.Definitive diagnosis of multiple myeloma from rib specimens resected at thoracotomy in a patient with lung cancer.Treatment of multiple myeloma in the elderly: realities and hopes.Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis.Management of Elderly Patients with Plasma Cell Myeloma.Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis.Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.

P2860

Q28199907-E1DEEF56-0258-416F-9CC3-FD68F7E226B5 Q34034447-3C44EB1F-48B6-404A-BEEF-AABCB8A82D53 Q34361282-E787E82C-DC78-4216-B71D-21F4D45E6DE3 Q36051084-F242D6CF-0458-4293-9647-DAA32ACCB8F1 Q36613990-D4791A99-87E0-409D-A61C-B8BDAF44E454 Q36616493-FFB3A7CC-2DFC-46DC-AA66-71451FE8DC12 Q36689152-AEE0763C-A57F-4177-889D-5E0B74ECAC34 Q36725401-066C3CD2-241B-4538-A0A0-3230E6EAFFFE Q36879132-ADB7DDA3-9FFE-4CAE-AC13-763BC5F79C2D Q36916889-AA7BE7F4-FEB9-4430-AD21-4BB777BA68DE Q37132903-A9B6EC1E-CCCC-4342-BBC5-CE1A53D939C4 Q37160347-71BFAB39-AD56-46FE-A659-264AE0486C6A Q37189281-33CCABF5-7886-4F53-B33D-5FBCA8919A44 Q37300004-C9980382-8156-4ADD-B3C1-922ADA6978A5 Q37303213-3A0CC65E-9184-473C-A696-B39B7417C7F7 Q37515416-5837EF47-55FE-4689-8BC3-0ECD4774E7B8 Q37618475-9B2CB31C-E6B2-491D-A588-F1FFA0DF7400 Q37721007-595D7732-0EE2-4CF1-B306-0685F8DF392F Q37809535-BC61D54B-9A1F-4312-A7B0-1FEF6A1DF83F Q37831402-4EE285D4-58D9-4E9C-914A-268F6996A50C Q39001325-21A5F335-86A4-45EB-9E5F-9AFF95BBA6BF Q44190664-73F310B6-B63A-45F1-8A5D-F1652B7AF566 Q44619463-59A1417E-E77A-4CD9-B389-573F503F0B02

P2860

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

http://www.wikidata.org/entity/Q46664514

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

@en

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

@nl

type

label

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

@en

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

@nl

prefLabel

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

@en

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

@nl

P1433

Q46664514-E32B23D6-1D57-46FA-A9E2-7419E689BF90

P1476

Q46664514-920F89A1-2CEE-4164-A901-5897673E17D4

P2093

Q46664514-050ADEE3-69AB-4BD4-909D-CBFD7B54E0BC

Q46664514-2E055C4C-C95E-4555-97C0-7B5750D68B3E

Q46664514-6B3FD87A-873B-4182-AACA-ADA9385A12CC

Q46664514-77A4F0A1-52BF-4819-B79D-7E5299BA24C5

Q46664514-A78A0936-395F-48DB-B939-69C6F6427691

Q46664514-ABA3EF19-3026-4D8F-9AE5-970E0C2C4A52

Q46664514-CE88680D-026F-45F8-A36C-823720B6E352

Q46664514-D5D785F7-1430-48DC-B5D8-5AEF0551D049

P304

Q46664514-EC5E12E8-377F-43D4-A7E1-B8D3236C0193

P31

Q46664514-3A243AFD-5F14-49B9-BB80-7454564E789F

P356

Q46664514-3ED87473-4D10-446B-800A-E4B5B549953E

P407

Q46664514-2DDDA115-8B11-4797-B9AA-4D0616DCC127

P433

Q46664514-9C6344B9-0190-45DC-B454-C37D73211742

P478

Q46664514-63CC45F6-8CE1-47C8-83F3-EDE8184BBFB4

P50

Q46664514-417DEF60-6D56-4F0C-B533-9AC278EDCB9D

Q46664514-98999A9F-DF95-4A74-8086-7C2AED68A6AC

P577

Q46664514-E8C6DC26-E212-46F5-B849-3BF6160E0033

P5875

Q46664514-A2611F5F-220E-477C-B328-1220650E1119

P698

Q46664514-E063D5D7-830E-4F2F-AE81-3DB38DE7544A

P921

Q46664514-A6109390-71E8-4FA9-9D34-63DAF590025F

P356

P1433

P1476

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

@en

P2093

Alessandra Bertola

http://www.w3.org/2001/XMLSchema#string

Clotilde Cangialosi

http://www.w3.org/2001/XMLSchema#string

Mariella Grasso

http://www.w3.org/2001/XMLSchema#string

Mario Boccadoro

http://www.w3.org/2001/XMLSchema#string

Martina Nunzi

http://www.w3.org/2001/XMLSchema#string

Patrizia Falco

http://www.w3.org/2001/XMLSchema#string

Tommaso Caravita

http://www.w3.org/2001/XMLSchema#string

Vincenzo Callea

http://www.w3.org/2001/XMLSchema#string

P304

1428-1433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.21342

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Pellegrino Musto

Antonio Palumbo

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7643346

http://www.w3.org/2001/XMLSchema#string

P698

16116606

http://www.w3.org/2001/XMLSchema#string

P921